Age-related macular degeneration is the most common cause for the loss of central vision beyond the age of 50 in industrial nations. Triplication of the number of affected patients is expected over the next 25 years. Especially over the last years the standard of knowledge regarding etiology, risk factors, diagnostics and therapy of this retina illness has substantially grown - this will be covered in this up-to-date multi-authored work. Apart from epidemiologically and genetically identified risk factors both the various pathophysiological aspects including the role of the complement system and clinical manifestations including OCT and angiographic characteristics are clearly represented. Furthermore, the different therapeutic approaches are presented and discussed, including proven procedures such as intravitreal anti-VEGF therapy and seeing-aid systems, in addition to the latest and upcoming methods in the area of pharmacology. The volume is well-illustrated and tables and summaries complete the presentation.
Publisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG
Number of pages: 320
Weight: 943 g
Dimensions: 260 x 195 x 20 mm
Edition: 2nd ed. 2012
From the reviews of the second edition:
"This is an excellent, all-inclusive review of macular degeneration with up-to-date information and good illustrations to help simplify a complex disease. ... this book is not only for ophthalmologists and optometrists from the resident level and up, it is also appropriate for basic scientists looking to get the big picture on this disease. ... Illustrations are quite good and I found the tables and summaries quite helpful. ... This is a high quality book." (Ayham Skaf, Doody's Book Reviews, April, 2013)
You may also be interested in...
Please sign in to write a review